BioCentury | Jan 12, 2019
Finance

JPM jump-starts 2019

About three quarters of the more than 200 biopharma companies presenting at the 2019 J.P. Morgan Healthcare Conference saw their stock prices rise last week. Leading the pack was the 53% jump by Insmed Inc....
BioCentury | Jan 9, 2018
Finance

Stars in China

A major clinical flop and a spate of weak earnings reports by U.S. large cap biotechs reverberated throughout the sector in the fourth quarter, breaking a three-quarter-long streak of outperformance. Across all market cap bands,...
BioCentury | Jul 7, 2017
Finance

Generalists needed

Following a nearly two-year political overhang on the biotech sector, buysiders believe sentiment once again may be turning positive and starting to catch up with the industry’s positive fundamentals. As evidence, they point to the...
BC Week In Review | Jun 16, 2017
Financial News

GenMark raises $75M in upsized follow-on

On June 13, molecular diagnostics company GenMark Diagnostics Inc. (NASDAQ:GNMK) raised $75 million through the sale of 6.4 million shares at $11.75 in an upsized follow-on underwritten by JPMorgan, BofA Merrill Lynch, William Blair, Cowen...
BC Extra | Jun 14, 2017
Financial News

GenMark raises $75M in upsized follow-on

Molecular diagnostics company GenMark Diagnostics Inc. (NASDAQ:GNMK) raised $75 million through the sale of 6.4 million shares at $11.75 in an upsized follow-on underwritten by JPMorgan, BofA Merrill Lynch, William Blair, Cowen and Raymond James....
BC Week In Review | Apr 26, 2017
Clinical News

ePlex Blood Culture Identification Fungal Pathogen Panel regulatory update

GenMark received CE Mark approval for its ePlex Blood Culture Identification Fungal Pathogen Panel to detect fungal blood stream infections in blood samples. The in vitro diagnostic runs on the company’s ePlex Sepsis Solution platform....
BC Extra | Jun 26, 2015
Company News

Management tracks

Rare disease play Aegerion Pharmaceuticals Inc. (NASDAQ:AEGR) hired Gregory Perry as CFO. Perry was CFO at Eleven Biotherapeutics Inc. (NASDAQ:EBIO). Inhalable therapies company Pulmatrix Inc. (NASDAQ:PULM) hired William Duke as CFO. He was CFO at...
BC Week In Review | Jan 19, 2015
Financial News

GenMark Diagnostics financial update

GenMark Diagnostics Inc. (NASDAQ:GNMK), Carlsbad, Calif.   Business: Diagnostic   Date announced: 2015-01-12   Note: GenMark secured a $40 million debt facility from GE Capital’s Healthcare Financial Services.  ...
BC Week In Review | Aug 18, 2014
Company News

GenMark Diagnostics board of directors update

GenMark Diagnostics Inc. (NASDAQ:GNMK), Carlsbad, Calif.   Business: Diagnostic   Appointed: James Fox, a director, as chairman; he replaces Christopher Gleeson, who is retiring  ...
BC Week In Review | May 19, 2014
Company News

GenMark Diagnostics management update

GenMark Diagnostics Inc. (NASDAQ:GNMK), Carlsbad, Calif.   Business: Diagnostic   Hired: Scott Mendel as CFO, formerly CFO of Active Network LLC; he succeeds Richard Slansky  ...
Items per page:
1 - 10 of 57
BioCentury | Jan 12, 2019
Finance

JPM jump-starts 2019

About three quarters of the more than 200 biopharma companies presenting at the 2019 J.P. Morgan Healthcare Conference saw their stock prices rise last week. Leading the pack was the 53% jump by Insmed Inc....
BioCentury | Jan 9, 2018
Finance

Stars in China

A major clinical flop and a spate of weak earnings reports by U.S. large cap biotechs reverberated throughout the sector in the fourth quarter, breaking a three-quarter-long streak of outperformance. Across all market cap bands,...
BioCentury | Jul 7, 2017
Finance

Generalists needed

Following a nearly two-year political overhang on the biotech sector, buysiders believe sentiment once again may be turning positive and starting to catch up with the industry’s positive fundamentals. As evidence, they point to the...
BC Week In Review | Jun 16, 2017
Financial News

GenMark raises $75M in upsized follow-on

On June 13, molecular diagnostics company GenMark Diagnostics Inc. (NASDAQ:GNMK) raised $75 million through the sale of 6.4 million shares at $11.75 in an upsized follow-on underwritten by JPMorgan, BofA Merrill Lynch, William Blair, Cowen...
BC Extra | Jun 14, 2017
Financial News

GenMark raises $75M in upsized follow-on

Molecular diagnostics company GenMark Diagnostics Inc. (NASDAQ:GNMK) raised $75 million through the sale of 6.4 million shares at $11.75 in an upsized follow-on underwritten by JPMorgan, BofA Merrill Lynch, William Blair, Cowen and Raymond James....
BC Week In Review | Apr 26, 2017
Clinical News

ePlex Blood Culture Identification Fungal Pathogen Panel regulatory update

GenMark received CE Mark approval for its ePlex Blood Culture Identification Fungal Pathogen Panel to detect fungal blood stream infections in blood samples. The in vitro diagnostic runs on the company’s ePlex Sepsis Solution platform....
BC Extra | Jun 26, 2015
Company News

Management tracks

Rare disease play Aegerion Pharmaceuticals Inc. (NASDAQ:AEGR) hired Gregory Perry as CFO. Perry was CFO at Eleven Biotherapeutics Inc. (NASDAQ:EBIO). Inhalable therapies company Pulmatrix Inc. (NASDAQ:PULM) hired William Duke as CFO. He was CFO at...
BC Week In Review | Jan 19, 2015
Financial News

GenMark Diagnostics financial update

GenMark Diagnostics Inc. (NASDAQ:GNMK), Carlsbad, Calif.   Business: Diagnostic   Date announced: 2015-01-12   Note: GenMark secured a $40 million debt facility from GE Capital’s Healthcare Financial Services.  ...
BC Week In Review | Aug 18, 2014
Company News

GenMark Diagnostics board of directors update

GenMark Diagnostics Inc. (NASDAQ:GNMK), Carlsbad, Calif.   Business: Diagnostic   Appointed: James Fox, a director, as chairman; he replaces Christopher Gleeson, who is retiring  ...
BC Week In Review | May 19, 2014
Company News

GenMark Diagnostics management update

GenMark Diagnostics Inc. (NASDAQ:GNMK), Carlsbad, Calif.   Business: Diagnostic   Hired: Scott Mendel as CFO, formerly CFO of Active Network LLC; he succeeds Richard Slansky  ...
Items per page:
1 - 10 of 57